Cathay Capital, established in 2006, is a prominent international private equity firm headquartered in Paris, France. With a team of 60 professionals across offices in New York, Shanghai, Beijing, Paris, Munich, and Silicon Valley, the firm specializes in cross-border investments, supporting the international expansion of middle-market companies in North America, China, and Europe. Cathay Capital focuses on investing in various sectors, including consumer products, healthcare, advanced manufacturing, and technology, with a particular emphasis on French and Chinese companies. The firm has successfully completed 59 platform company investments across three continents, with a total of $1.5 billion in assets under management. Cathay Capital's unique value-creation strategy and multicultural team enable it to build and grow companies on a long-term basis.
3001-3002 Kerry Parkside, No.1155 Fangdian Road Pudong, Shanghai, China
1806, Kerry Parkside No.1155 Fangdian Road Pudong, Shanghai, China
Thierry Auzel
Investment Director
Daniel Balmisse
Managing Partner
Bruno Bezard
Managing Partner
Ming-Po Cai
Founder, Chairman and CEO
Mingpo Cai
Founder and President
Jinchen Cai
Vice President
Jackson Catalano
Associate
Siqi Chen
Partner
Jean-Francois Cochy
Associate
Lijun Ding
Associate
Jérémie Falzone
Partner
Wenyun Fang
Associate
Liu Feng
Investment Director
Caroline Folleas
Partner
Maximillian Gairard
Associate
Philip Galfe
Associate
Kejia Li
Investment Director
Jun MA
Partner
Niccolò Maino
Associate
Edouard Moinet
Co-Founder and Managing Partner
Marion Prieur
Associate
Jean-Marc Prunet
Partner
Andre Puong
Partner
Ricky Roman
Investment Director
Richard Roman
Investment Director
Benoît Seringe
Investment Director
Jianfei Sun
Investment Director
Bertrand Uchan
Vice President
Félix Wang
Vice President
Fabien Wesse
Managing Partner
Mark Woods
Partner and Head of North American Private Equity
Mark Woods
Partner
Xiao Xiao
Vice President
Minglang Xie
Vice President
Zhao Jing
Managing Partner
Kangjing Zheng
Associate
Zitian Zhu
Vice President
Past deals in Paris
Ganymed Robotics
Series B in 2022
Ganymed Robotics SAS is a medical device company based in Paris, France, established in 2018. The company specializes in developing advanced robotics technologies and software aimed at enhancing surgical precision in orthopedic procedures, particularly focusing on knee replacement surgeries. Its innovative therapeutic device is designed to improve patient outcomes and streamline the surgical process, enabling orthopedic surgeons to reduce operating times and enhance their overall experience. By integrating robotics into surgical practices, Ganymed Robotics aims to advance the efficiency of care delivery in the orthopedic field.
Finalcad
Private Equity Round in 2022
Finalcad is a technology company based in Paris, founded in 2011, that specializes in mobile applications and predictive analytics for the construction industry. Its platform facilitates construction project management by enhancing the field experience for workers and adapting to various on-site challenges and project requirements. Finalcad's solutions support stakeholders—including contractors, architects, and owners—through all phases of construction, from design to operation and maintenance. The platform focuses on improving quality, reducing costs, and enabling effective risk management by providing tools for progress reporting, defect management, and quality control. Since its inception, Finalcad has contributed to over 10,000 projects across 30 countries, playing a significant role in the digital transformation of the construction sector.
TISSIUM
Series C in 2021
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
Le Wagon
Series A in 2020
Le Wagon SAS is a coding bootcamp founded in 2013 and headquartered in Paris, France. The company provides intensive training programs designed to teach students how to develop web applications from scratch. Its curriculum covers essential skills in web development, object-oriented programming, programming languages, and data science. Le Wagon aims to equip students with the technical expertise and entrepreneurial mindset necessary for launching careers as software developers or starting their own ventures. Through hands-on training and pre-acceleration programs, the bootcamp empowers aspiring entrepreneurs to transform their ideas into viable prototypes, fostering innovation in the tech industry.
Another Brain
Venture Round in 2018
Another Brain, SA is a Paris-based company founded in 2017 that specializes in the development and manufacturing of bio-inspired chipsets designed for artificial intelligence and robotics applications. These innovative chipsets facilitate autonomous and unsupervised data extraction, enabling embedded pattern recognition and processing without reliance on external databases. They can detect and store multiple patterns simultaneously and learn from previously encountered patterns. The company also offers software tools to assist users in integrating the chipsets and conducting simulations. Another Brain's technology has diverse applications across various industries, including smart sensors, Internet of Things (IoT), smart cars, smart homes, robotics, drones, security, biometrics, defense, and data center optimization. By enhancing the capabilities of AI beyond traditional deep learning approaches, Another Brain aims to revolutionize how information is processed and utilized in numerous sectors.
Mauboussin
Private Equity Round in 2010
Mauboussin is a French manufacturer and designer of jewelry, offering a range of products for both men and women. Originally known for its exclusive fine jewelry, the company has since expanded its offerings to include "new accessible luxury" items, which are marketed through innovative campaigns that challenge industry norms. The design of all jewelry pieces is handled by a creative team based in Paris. Mauboussin operates 75 stores and distributes its products through concessions in department stores and various multi-brand jewelry shops. The company's portfolio includes wedding jewelry and gemstones, catering to a diverse customer base.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.